Home
About
Overview
Sharing Data
ORCID
Help
History (17)
A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.
Light-activated DNA binding in a designed allosteric protein.
Clinical Trial, Phase I
Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity.
Under surveillance.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Under surveillance.
Under surveillance. Am J Sports Med. 2010 Dec; 38(12):2391-3.
View in:
PubMed
subject areas
Authorship
Biomedical Research
Ethics, Research
Humans
Plagiarism
Publishing
Software
authors with profiles
Bruce Reider